科研级Ipilimumab生物类似药，抗人CTLA-4单克隆抗体（Ipilimumab Biosimilar, Anti-Human CTLA-4 Monoclonal Antibody）。科研级Ipilimumab生物类似蛋白仅用于研究用途(RUO)。重组人IgG1同型对照（Recombinant human IgG1 isotype controls）是可用的。样品制备条件和最佳稀释度应由研究者通过实验确定。科研级Ipilimumab生物类似药，抗人CTLA-4单克隆抗体多找找，一定能找到！特此声明：多找找推广的所有产品和服务的价格、货期和规格等信息如有更改，恕不另行通知。除非另有说明，多找找推广的所有目录和定制产品仅限于科研使用，不得用于人类或动物的诊断或治疗。货号:C050P产品名称:科研级Ipilimumab生物类似药，抗人CTLA-4单克隆抗体英文名:Ipilimumab Biosimilar, Anti-Human CTLA-4 Monoclonal Antibody供货商名称:Syd Labs, Inc.公司名:Syd Labs别称:cytotoxic T-lymphocyte?associated antigen 4, cytotoxic T-lymphocyte antigen 4,CD152, CTLA4概述:用CHO细胞产生的重组人IgG1单克隆抗体（Ipilimumab Biosimilar, Anti-Human CTLA-4 Monoclonal Antibody）来源：抗人CTLA-4单克隆抗体ipilimumab生物类似药是使用ipilimumab生物类似药 CHO 稳定细胞系生产的。特异性：体内科研级ipilimumab生物类似药特异性结合人CTLA4。应用:ELISA，中和，功能分析，如生物分析PK和ADA分析，以及研究易匹单抗影响的生物途径的分析。抗体形式：0.2 μM过滤溶液，pH 7.0，不含稳定剂或防腐剂。内毒素：根据 LAL 方法，≤1 EU每1mg 蛋白质。提供特级Ipilimumab生物类似药，抗人CTLA-4单克隆抗体（Ipilimumab Biosimilar, Anti-Human CTLA-4 Monoclonal Antibody，内毒素≤0.05 EU/mg)。纯度：>95%（在还原条件下通过SDS-PAGE测定）运输：科研级Ipilimumab生物类似药，抗人CTLA-4单克隆抗体（Ipilimumab Biosimilar, Anti-Human CTLA-4 Monoclonal Antibody）用冰袋运输。收到后，请立即将其存放在下面建议的温度下。稳定性与存储：使用手动除霜冰箱并避免重复冻融循环。 自收到之日起 1 个月，如果保存在2 至 8°C。 自收到之日起 3 个月，如果保存在-20 至 -70°C。注意事项：最便宜的体内科研级重组人IgG1 kappa同型对照抗体和突变体（In Vivo Grade Recombinant Human IgG1 kappa Isotype Control Antibody mutant）;与经测试的人体样本的特异性结合程度低或无特异性结合;人源化可变区和人IgG1 kappa恒定区;可提供嵌合版本和优质级(内毒素≤0.05 EU/mg)。C050P:科研级 Ipilimumab生物类似药，抗人CTLA-4单克隆抗体（Ipilimumab Biosimilar, Anti-Human CTLA-4 Monoclonal Antibody）背景知识What is Ipilimumab biosimilar research grade（科研级Ipilimumab单抗生物类似药）? Ipilimumab is a human cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody used to treat metastatic or unresectable melanoma.Ipilimumab is a fully humanized IgG1 monoclonal antibody（IgG1单克隆抗体） that blocks cytotoxic T lymphocyte antigen-4 (CTLA-4). Blocking CTLA-4 removes an inhibitory signal from reducing the activity of T lymphocytes.Cytotoxic T-lymphocyte antigen-4 (CTLA-4) is an inhibitory molecule that competes with the stimulatory CD28 for binding to B7 on antigen presenting cells. CTLA-4 and CD28 are both presented on the surface of T-cells. Ipilimumab is a human IgG1 that binds CTLA-4, preventing the inhibition of T-cell mediated immune responses to tumors.Syd Labs提供以下科研级抗CTLA-4抗体生物类似药（research grade anti-CTLA-4 antibody biosimilars）:科研级Ipilimumab生物类似药，抗人CTLA-4单克隆抗体（Ipilimumab Biosimilar, research grade, anti-human CTLA-4 monoclonal antibody）科研级Tremelimumab生物类似药，抗人CTLA-4单克隆抗体（Tremelimumab Biosimilar, research grade, anti-human CTLA-4 monoclonal antibody）PD-1是T细胞调节因子CD28/CTLA-4家族的一员。Syd Labs提供以下科研级抗PD-L1 / PD-1抗体生物类似蛋白（research grade anti-PD-L1 / PD-1 antibody biosimilar proteins）:科研级Atezolizumab生物类似药，抗人PD-L1单克隆抗体（Atezolizumab biosimilar, research grade, anti-human PD-L1 monoclonal antibody）科研级Avelumab生物类似药，抗人PD-L1单克隆抗体（Avelumab biosimilar, research grade, anti-human PD-L1 monoclonal antibody）科研级Camrelizumab生物类似药，抗人PD-1单克隆抗体（Camrelizumab biosimilar, research grade, anti-human PD-1 monoclonal antibody）科研级Cemiplimab生物类似药，抗人PD-1单克隆抗体（Cemiplimab biosimilar, research grade, anti-human PD-1 monoclonal antibody）科研级Durvalumab生物类似药，抗人PD-L1单克隆抗体（Durvalumab biosimilar, research grade, anti-human PD-L1 monoclonal antibody）科研级Nivolumab生物类似药，抗人PD-1单克隆抗体（Nivolumab biosimilar, research grade, anti-human PD-1 monoclonal antibody）科研级Pembrolizumab生物类似药，抗人PD-1单克隆抗体（Pembrolizumab biosimilar, research grade, anti-human PD-1 monoclonal antibody）科研级Spartalizumab生物类似药，抗人PD-1单克隆抗体（Spartalizumab biosimilar, research grade, anti-human PD-1 monoclonal antibody）请记住我们的产品信息: 科研级Ipilimumab生物类似药，抗人CTLA-4单克隆抗体: C050P Syd Labs （Ipilimumab Biosimilar, Anti-Human CTLA-4 Monoclonal Antibody）关键词：Pembrolizumab生物类似药、抗人PD-1单克隆抗体、Pembrolizumab Biosimilar、Anti-human PD-1 Monoclonal Antibody、Tremelimumab生物类似药、Tremelimumab Biosimilar、Atezolizumab生物类似药、Avelumab生物类似药、Camrelizumab生物类似药、Cemiplimab生物类似药、Durvalumab生物类似药、Nivolumab生物类似药、Pembrolizumab生物类似药、Spartalizumab生物类似药、Syd Labs武汉代理、Syd Labs杭州代理、Syd Labs广州代理、Syd Labs苏州代理、Syd Labs北京代理从多找找科技购买科研级Ipilimumab生物类似药，抗人CTLA-4单克隆抗体(C050P)，偶有促销活动，请联系获取促销码。

---